Orencia clickject 125 MG/mlml
Ended Awarded
- Contract number
- SPE2DB25FAWKR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,592
Award facts
- Contract value 100% obligated
- $37,591.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,591.56 to DMS Pharmaceutical Group Inc. for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order from its facility in Conshohocken, Pennsylvania. The company leverages its position as a critical supplier within the federal pharmaceutical supply chain, serving military and federal healthcare facilities nationwide.
This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products supporting medical supply needs across Department of Defense healthcare sites worldwide. The company's contract portfolio demonstrates consistent success in competing for federal pharmaceutical procurement opportunities, with awards covering an extensive range of branded and generic prescription drugs, biologics, injections, and specialty medications essential to military health operations.
Quick answers
Who was awarded contract SPE2DB25FAWKR?
SPE2DB25FAWKR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FAWKR worth?
The government has obligated $37,592 on SPE2DB25FAWKR.
Is contract SPE2DB25FAWKR an order under another contract?
Yes. SPE2DB25FAWKR is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWKR competed?
The extent of competition for SPE2DB25FAWKR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award